Telix Pharmaceuticals Ltd
ASX:TLX

Watchlist Manager
Telix Pharmaceuticals Ltd Logo
Telix Pharmaceuticals Ltd
ASX:TLX
Watchlist
Price: 25.28 AUD 0.12%
Market Cap: 8.5B AUD

Wall Street
Price Targets

TLX Price Targets Summary
Telix Pharmaceuticals Ltd

Wall Street analysts forecast TLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLX is 34.81 AUD with a low forecast of 29.43 AUD and a high forecast of 37.8 AUD.

Lowest
Price Target
29.43 AUD
16% Upside
Average
Price Target
34.81 AUD
38% Upside
Highest
Price Target
37.8 AUD
50% Upside
Telix Pharmaceuticals Ltd Competitors:
Price Targets
IMNM
Immunome Inc
185% Upside
TSHA
Taysha Gene Therapies Inc
142% Upside
FYB
Formycon AG
157% Upside
688373
Shanghai MicuRx Pharmaceutical Co Ltd
15% Downside
VCYT
Veracyte Inc
63% Upside
005690
Pharmicell Co Ltd
41% Upside
SBTX
SkinBioTherapeutics PLC
203% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
37% Upside

Revenue
Forecast

Revenue Estimate
Telix Pharmaceuticals Ltd

For the last 6 years the compound annual growth rate for Telix Pharmaceuticals Ltd's revenue is 299%. The projected CAGR for the next 3 years is 35%.

299%
Past Growth
35%
Estimated Growth
Estimates Accuracy
-22%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Telix Pharmaceuticals Ltd

The compound annual growth rate of Telix Pharmaceuticals Ltd's operating income for the next 3 years is 88%.

N/A
Past Growth
88%
Estimated Growth
Estimates Accuracy
19%
Average Beat

Net Income
Forecast

Net Income Estimate
Telix Pharmaceuticals Ltd

The compound annual growth rate of Telix Pharmaceuticals Ltd's net income for the next 3 years is 97%.

N/A
Past Growth
97%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TLX's stock price target?
Price Target
34.81 AUD

According to Wall Street analysts, the average 1-year price target for TLX is 34.81 AUD with a low forecast of 29.43 AUD and a high forecast of 37.8 AUD.

What is Telix Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
35%

For the last 6 years the compound annual growth rate for Telix Pharmaceuticals Ltd's revenue is 299%. The projected CAGR for the next 3 years is 35%.

What is Telix Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
88%

The compound annual growth rate of Telix Pharmaceuticals Ltd's operating income for the next 3 years is 88%.

What is Telix Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
97%

The compound annual growth rate of Telix Pharmaceuticals Ltd's net income for the next 3 years is 97%.

Back to Top